University Hospitals Is First in Cleveland To Offer GT Medical Technologies New Targeted Therapy for Brain Tumors
GammaTile® Therapy Is Shown To Slow Brain Tumor Progression, Designed To Improve Patient and Caregiver Quality of Life
News provided by
Share this article
Share this article
CLEVELAND, Feb. 17, 2021 /PRNewswire/ A University Hospitals Cleveland Medical Center neurosurgeon is among the first in the region to begin offering GammaTile
® Therapy, a new approach to treating brain tumors. GammaTile Therapy is an FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) that is designed to delay tumor regrowth for patients with brain tumors while protecting healthy brain tissue. University Hospitals Seidman Cancer Center is the first to offer this to patients with brain tumors in Cleveland.
Deals with Lake Health and Western Reserve give University Hospitals ‘all the pieces of the puzzle
Dr. Cliff Megerian, president and incoming CEO of UH
In the final months of 2020, University Hospitals rounded out a year of great uncertainty financial and otherwise with two deals that significantly expand the health system s regional footprint.
In November, the system gained a minority interest in Western Reserve Hospital, an independent, physician-owned hospital in Cuyahoga Falls, giving UH its first inpatient location in Summit County. In December, Lake Health agreed to join University Hospitals, ending the Lake County health system s search for a partner that began in early March, just days before the first cases of COVID-19 were detected in Ohio.
E-Mail
New research from the University of Iowa and University Hospitals Cleveland Medical Center demonstrates that offspring can be protected from the effects of prenatal stress by administering a neuroprotective compound during pregnancy.
Working in a mouse model, Rachel Schroeder, a student in the UI Interdisciplinary Graduate Program in Neuroscience, drew a connection between the work of her two mentors, Hanna Stevens, MD, PhD, UI associate professor of psychiatry and Ida P. Haller Chair of Child and Adolescent Psychiatry, and Andrew A. Pieper, MD, PhD, a former UI faculty member, now Morley-Mather Chair of Neuropsychiatry at Case Western Reserve University and Investigator and Director of the Neurotherapeutics Center at the Harrington Discovery Institute, University Hospitals Cleveland Medical Center.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Adam Perer Joins Blue Spark Technologies’ TempTraq Advisory Board
January 19, 2021 GMT
CLEVELAND (BUSINESS WIRE) Jan 19, 2021
Blue Spark Technologies, Inc. today announced that Adam Perer has joined its TempTraq advisory board. The advisory board consists of key leaders from the medical, tech and business communities and helps drive strategic initiatives within Blue Spark.
ADVERTISEMENT
Perer is assisting Blue Spark to build out new, innovative, features on its TempTraq continuous remote body temperature monitoring platform, with the first focus on building out Blue Spark’s neural network, initially based on its TempTraq continuous body temperature monitoring platform and robust data sets. The goal is to build a platform that can predictively inform healthcare providers on potential changes in disease states, well before they become critical. Blue Spark has seen encouraging resear
E-Mail
CLEVELAND - In a new paper, researchers describe their development of a near-real time spatial assessment of COVID-19 cases to help guide local medical responses to clusters of outbreaks of the virus at the local level.
The paper, entitled Geographic monitoring for early disease detection (GeoMEDD), appeared in the Dec. 10 issue of Nature
Scientific Reports and comes from researchers at Case Western Reserve University (CWRU) School of Medicine, University Hospitals (UH) Cleveland Medical Center, and Texas A & M University.
While developing a tracking system during the beginning stages of the COVID-19 pandemic, the authors realized that there was a need to refocus more traditional spatial mapping towards a more granular cluster detection methodology that provides syndromic surveillance, or early indicators of emergent disease by leveraging a health system s access to data streams from various sources which account for location and timing of cases.